Tumor News and Research

RSS

Multifunctional nanoparticle system may be a promising therapeutic way for breast cancer therapy

In this new article publication from Acta Pharmaceutica Sinica B, authors Yun Yang, Danrong Hu, Yi Lu, Bingyang Chu, Xinlong He, Yu Chen, Yao Xiao, Chengli Yang, Kai Zhou, Liping Yuan and Zhiyong Qian from Sichuan University, Chengdu discuss tumor-targeted/reduction-triggered composite multifunctional nanoparticles for breast cancer chemo-photothermal combinational therapy.

18 Jun 2022

Study points to a new direction for the development of NAMPT-targeted cancer therapies

In this new article publication from Acta Pharmaceutica Sinica B, authors Ying Wu, Congying Pu, Yixian Fu, Guoqiang Dong, Min Huang and Chunquan Sheng from Second Military Medical University, Shanghai, China and University of Chinese Academy of Sciences, Shanghai, China discuss how NAMPT-targeting PROTAC promotes antitumor immunity via suppressing myeloid-derived suppressor cell expansion.

18 Jun 2022

Diagnostic mammograms' accuracy may differ across racial and ethnic groups

The accuracy of diagnostic mammograms differed across racial and ethnic groups, with variation in several measures of diagnostic performance.

17 Jun 2022

Conceptual framework to examine the patterns of copy number alterations in human cancer

A new study published in Nature presented a conceptual framework to examine the patterns of copy number alterations in human cancer.

17 Jun 2022

International researchers will receive $25 million award to investigate the early stages of cancer development

A world-class team of researchers co-led by UC San Francisco's Allan Balmain, PhD, FRS, has been selected to receive a $25 million Cancer Grand Challenges award to investigate the very early stages of cancer development.

16 Jun 2022

How does gut microbiota impact mental health in 18–25s?

In a recently published article in the International Journal of Molecular Sciences, scientists have described the importance of the gut-brain-microbiota axis in establishing optimal mental health in emerging adulthood (ages 18–25).

16 Jun 2022

New liquid biopsy assay enables prediction of treatment response in patients with esophageal cancer

Biomarkers are like the X on a treasure map, but instead of indicating the location of unearthed riches, they indicate an individual's health status.

16 Jun 2022

Combination drug strategy activates natural killer cell-mediated immunity to attack tumors

Most skin cancer drugs that activate the immune system work by triggering immune cells, called T cells, to attack tumors, but when T cells are activated for too long, they can wear out and cease to function.

16 Jun 2022

Four interdisciplinary teams will receive $100 million to solve the toughest challenges in cancer research

The Cancer Grand Challenges program will award $100 million to four interdisciplinary teams from around the world to solve some of the toughest challenges in cancer research.

16 Jun 2022

UiO researchers find 13 special genes related to epigenetic changes in cancer samples

Abnormal epigenetic changes are observed in the development of multiple types of cancer. Researchers at Centre for Molecular Medicine Norway (UiO) found 13 special genes linked to epigenetic changes in cancer samples.

16 Jun 2022

New component of cell death process could play key role in infection-fighting strategy

Researchers have unmasked a component of the cell death process that could play a vital role in a better infection-fighting strategy.

16 Jun 2022

Moffitt researchers reveal a mechanism leading to drug resistance in prostate cancer

Prostate cancer is the most common cancer among men in the United States. Many patients can live long lives due to early detection and treatment with androgen deprivation therapy.

16 Jun 2022

Researchers create first bona fide mouse model of Merkel cell carcinoma

A team of researchers at the University of Michigan Rogel Cancer Center were the first to generate a bona fide mouse model of a Merkel cell carcinoma, a rare and potentially aggressive form of skin cancer.

15 Jun 2022

Scientists publish a robust framework to analyze chromosomal instability in human cancers

Scientists have found a way to identify and interpret 'signatures' that reveal the complex genetic causes of some of the deadliest cancers – which often have a survival rate of less than 10%.

15 Jun 2022

Androgen receptor signaling affects response to targeted therapy in people with melanoma

Androgen receptor (AR) signaling affects response to BRAF/MEK inhibitor therapy in both males and females with melanoma, researchers from The University of Texas MD Anderson Cancer Center showed in a study published today in Nature.

15 Jun 2022

3D mammography may reduce the chance of advanced breast cancer diagnosis for some women

Advanced Cancer Is Reduced in Women with Most Dense Breasts and Highest Risk. For many women, breast cancer screening with a three-dimensional imaging technique called digital breast tomosynthesis (DBT) may not offer advantages over digital mammography, but for some it may reduce the chance of an advanced cancer diagnosis,

15 Jun 2022

Combination of three technologies makes potential treatment effective against aggressive brain tumor

A drug carrier able to reach the brain, bind to an aggressive type of tumor called glioblastoma multiforme, and release a chemotherapeutic agent has been tested for the first time by Brazilian researchers.

15 Jun 2022

Novel nanoparticle therapeutics shows promise to fight solid tumors

Researchers from Wake Forest University School of Medicine have discovered a possible new approach to treating solid tumors through the creation of a novel nanoparticle. Solid tumors are found in cancers such as breast, head and neck, and colon cancer.

14 Jun 2022

Preventive care may be free, but follow-up diagnostic tests can bring big bills

When Cynthia Johnson learned she would owe $200 out-of-pocket for a diagnostic mammogram in Houston, she almost put off getting the test that told her she had breast cancer.

14 Jun 2022

The potential mechanisms of SARS-CoV-2 to induce DNA damage

Researchers described potential mechanisms of coronaviruses that could lead to DNA damage and the potential link between SARS-CoV-2 activity and such mechanisms.

14 Jun 2022

Tumor News and Research

Multifunctional nanoparticle system may be a promising therapeutic way for breast cancer therapy

Study points to a new direction for the development of NAMPT-targeted cancer therapies

Diagnostic mammograms' accuracy may differ across racial and ethnic groups

Conceptual framework to examine the patterns of copy number alterations in human cancer

International researchers will receive $25 million award to investigate the early stages of cancer development

How does gut microbiota impact mental health in 18–25s?

New liquid biopsy assay enables prediction of treatment response in patients with esophageal cancer

Combination drug strategy activates natural killer cell-mediated immunity to attack tumors

Four interdisciplinary teams will receive $100 million to solve the toughest challenges in cancer research

UiO researchers find 13 special genes related to epigenetic changes in cancer samples

New component of cell death process could play key role in infection-fighting strategy

Moffitt researchers reveal a mechanism leading to drug resistance in prostate cancer

Researchers create first bona fide mouse model of Merkel cell carcinoma

Scientists publish a robust framework to analyze chromosomal instability in human cancers

Androgen receptor signaling affects response to targeted therapy in people with melanoma

3D mammography may reduce the chance of advanced breast cancer diagnosis for some women

Combination of three technologies makes potential treatment effective against aggressive brain tumor

Novel nanoparticle therapeutics shows promise to fight solid tumors

Preventive care may be free, but follow-up diagnostic tests can bring big bills

The potential mechanisms of SARS-CoV-2 to induce DNA damage

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News